CRESCENT BIOPHARMA, INC. (CBIO) Form 10-Q Quarterly Reports
CRESCENT BIOPHARMA, INC. (CBIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CBIO
CIK: 1253689
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerKenneth Richardson
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001628280-26-066006 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062709 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062707 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062706 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062705 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062703 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062701 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001628280-26-062700 | View SEC Doc Filr Page |
| S-8 | 2026-09-18 | — | S-8 | 0001628280-26-062634 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001628280-26-062529 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001628280-26-062526 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001628280-26-062213 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001628280-26-062211 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003420 | View SEC Doc Filr Page |
| EFFECT | 2026-07-31 | — | EFFECT Filing | 9999999995-26-002504 | View SEC Doc Filr Page |
| POS AM | 2026-07-30 | — | POS AM | 0001628280-26-050885 | View SEC Doc Filr Page |
| 424B3 | 2026-07-30 | — | 424B3 | 0001628280-26-050881 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001628280-26-050869 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001628280-26-050805 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-20 | — | SCHEDULE 13D/A Filing | 0001104659-26-085114 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | OWNERSHIP DOCUMENT | 0001104659-26-085113 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-14 | 8-K | 0001628280-26-048347 | View SEC Doc Filr Page |
| 424B5 | 2026-07-15 | — | 424B5 | 0001628280-26-048344 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-14 | 8-K | 0001628280-26-048151 | View SEC Doc Filr Page |
| 424B5 | 2026-07-14 | — | 424B5 | 0001628280-26-048144 | View SEC Doc Filr Page |